Copyright
©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2537-2541
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2537
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2537
Table 3 Comparison of study groups
| Sham | Budesonide | Levobupivacaine | Saline | P | |
| Weight loss | 10 (0-20) | 10 (0-25) | 10 (0-20) | 0 (0-10) | 0.016 |
| Macroscopic damage score | 0 (0-1) | 1(0-4) | 2 (0-5) | 4.5 (2-9) | 0.001 |
| Microscopic damage score | 0 (0-0.66) | 1.33 (0-3.33) | 0 (0-5.66) | 1.66 (0-4.33) | 0.014 |
| IL-6 | 0 (0-38.59) | 37.6 (20.3-85.4) | 32.3 (0-43.8) | 31.9 (7.7-144.8) | 0.004 |
| TNF-α | 0.1 (0-3.7) | 0.5 (0.2-45.7) | 0.2 (0.1-312) | 0.5 (0.2-255.9) | 0.152 |
- Citation: Duman U, Yilmazlar A, Ozturk E, Aker S, Sarandol E, Yilmazlar T. Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model. World J Gastroenterol 2010; 16(20): 2537-2541
- URL: https://www.wjgnet.com/1007-9327/full/v16/i20/2537.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i20.2537